Regulatory status Retatrutide and similar peptides are investigational not approved by the FDA or any regulator
Retatrutide May Be Studied for Other Health Conditions Retatrutide is mainly known for weight-loss research, but scientists are also studying it for other health problems
A 200-pound person who lost 50 pounds would typically regain 35-40 pounds over a full year, not overnight
You can change, pause, and cancel anytime
During your first consultation, we'll review your health history, discuss your goals, and create a plan for your specific needs
As more people become aware of these medications and the stigma associated with seeking treatment for obesity ebbs, this demand will continue to rise: Research from the University of Southern California showed a 442% increase in prescriptions for semaglutide between January 2021 and December 2023